Lexaria Bioscience (LEXX)
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which com...
- Open
- 9.310
- High
- 10.460
- Low
- 8.740
- Prev. Close
- 9.040
- Volume
- 35.11K
- Turnover
- 337.73K
- Avg Price
- 9.619
- Bid/Ask Ratio
- 19.05%
- Amplitude
- 19.03%
- 52wk High
- 23.250
- Volume Ratio
- 0.29
- Turnover Ratio
- 2.19%
Lexaria Bioscience Analyst Rating
View moreForecast & Rating
Jul 17, 2026Price forecast
$52.50408.72%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 15 hours ago
12 Health Care Stocks Moving In Monday's After-Market Session
- Tip Ranks · 19 hours ago
Lexaria Bioscience Regains Nasdaq Compliance, Stabilizing Listing
- PUBT · 19 hours ago
Lexaria regains Nasdaq bid price compliance, avoids delisting hearing
- benzinga_article · Aug 13 at 02:18 PM
Lexaria Bioscience Stock Rallies Thursday: What Investors Need to Know
- PUBT · Aug 13 at 08:00 AM
Lexaria signs material transfer agreement with PegBio to test DehydraTECH with GLP-1 molecule
- PUBT · Aug 10 at 04:07 PM
Lexaria risks Nasdaq delisting after missing $1 minimum bid price rule
